Position in NVO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$137,576,964
+$32,112,770 QoQ
Shares Held
2,869,774
0.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#30
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Markel Group Inc. holds $292,701,839 across 2 Drug Manufacturers - General names. NVO ranks #2 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
610,800 | $155,124,875 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
2,869,774 | $137,576,964 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,576,964 | 2,869,774 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $105,464,194 | 2,869,774 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $146,014,100 | 2,869,774 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $131,436,332 | 2,368,649 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $155,887,742 | 2,258,588 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $149,295,999 | 2,150,000 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $184,942,999 | 2,150,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $256,000,499 | 2,150,000 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $306,890,999 | 2,150,000 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $276,060,000 | 2,150,000 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $222,417,500 | 2,150,000 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $195,520,999 | 2,150,000 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $173,967,249 | 1,075,000 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $171,075,499 | 1,075,000 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $145,490,499 | 1,075,000 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $107,102,250 | 1,075,000 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $119,787,250 | 1,075,000 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $119,378,750 | 1,075,000 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $120,400,000 | 1,075,000 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $103,210,750 | 1,075,000 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $90,052,750 | 1,075,000 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $72,476,500 | 1,075,000 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $75,088,750 | 1,075,000 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $74,637,250 | 1,075,000 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $70,391,000 | 1,075,000 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $64,715,000 | 1,075,000 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||